相似文献
1
To Pretreat or Not to Pretreat (With Oral P2Y12 Antagonists)? That is the Question.
J Am Heart Assoc. 2017 Sep 22;6(9):e007288. doi: 10.1161/JAHA.117.007288.
2
Precatheterization Use of P2Y Inhibitors in Non-ST-Elevation Myocardial Infarction Patients Undergoing Early Cardiac Catheterization and In-Hospital Coronary Artery Bypass Grafting: Insights From the National Cardiovascular Data Registry.
J Am Heart Assoc. 2017 Sep 22;6(9):e006508. doi: 10.1161/JAHA.117.006508.
3
Implementation of contemporary oral antiplatelet treatment guidelines in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a report from the GReek AntiPlatelet rEgistry (GRAPE).
Int J Cardiol. 2013 Oct 15;168(6):5329-35. doi: 10.1016/j.ijcard.2013.08.007. Epub 2013 Aug 15.
4
Outcomes of Women and Men With Acute Coronary Syndrome Treated With and Without Percutaneous Coronary Revascularization.
J Am Heart Assoc. 2017 Jan 20;6(1):e004319. doi: 10.1161/JAHA.116.004319.
5
Revascularization Trends in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease Presenting With Non-ST Elevation Myocardial Infarction: Insights From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get with the Guidelines (NCDR ACTION Registry-GWTG).
Circ Cardiovasc Qual Outcomes. 2016 May;9(3):197-205. doi: 10.1161/CIRCOUTCOMES.115.002084. Epub 2016 May 10.
6
New antiplatelet agents in the treatment of acute coronary syndromes.
Arch Cardiovasc Dis. 2014 Mar;107(3):178-87. doi: 10.1016/j.acvd.2014.01.009. Epub 2014 Mar 11.
7
Comparison of Ticagrelor Versus Prasugrel for Inflammation, Vascular Function, and Circulating Endothelial Progenitor Cells in Diabetic Patients With Non-ST-Segment Elevation Acute Coronary Syndrome Requiring Coronary Stenting: A Prospective, Randomized, Crossover Trial.
JACC Cardiovasc Interv. 2017 Aug 28;10(16):1646-1658. doi: 10.1016/j.jcin.2017.05.064.
8
Benefits and risks of P2Y12 inhibitor preloading in patients with acute coronary syndrome and stable angina.
J Thromb Thrombolysis. 2017 Oct;44(3):303-315. doi: 10.1007/s11239-017-1529-6.
9
Use, patient selection and outcomes of P2Y12 receptor inhibitor treatment in patients with STEMI based on contemporary European registries.
Eur Heart J Cardiovasc Pharmacother. 2016 Jul;2(3):152-67. doi: 10.1093/ehjcvp/pvw003. Epub 2016 Jan 27.
10
Contemporary registries on P2Y12 inhibitors in patients with acute coronary syndromes in Europe: overview and methodological considerations.
Eur Heart J Cardiovasc Pharmacother. 2015 Oct;1(4):232-44. doi: 10.1093/ehjcvp/pvv024. Epub 2015 May 12.
本文引用的文献
1
Precatheterization Use of P2Y Inhibitors in Non-ST-Elevation Myocardial Infarction Patients Undergoing Early Cardiac Catheterization and In-Hospital Coronary Artery Bypass Grafting: Insights From the National Cardiovascular Data Registry.
J Am Heart Assoc. 2017 Sep 22;6(9):e006508. doi: 10.1161/JAHA.117.006508.
2
P2Y12-ADP receptor antagonists: Days of future and past.
World J Cardiol. 2016 May 26;8(5):327-32. doi: 10.4330/wjc.v8.i5.327.
3
2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
Circulation. 2014 Dec 23;130(25):2354-94. doi: 10.1161/CIR.0000000000000133. Epub 2014 Sep 23.
4
Prasugrel versus clopidogrel for acute coronary syndromes without revascularization.
N Engl J Med. 2012 Oct 4;367(14):1297-309. doi: 10.1056/NEJMoa1205512. Epub 2012 Aug 25.
5
Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial.
JAMA. 2012 Jan 18;307(3):265-74. doi: 10.1001/jama.2011.2002.
6
2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines.
Ann Thorac Surg. 2011 Mar;91(3):944-82. doi: 10.1016/j.athoracsur.2010.11.078.
7
Effectiveness of in-laboratory high-dose clopidogrel loading versus routine pre-load in patients undergoing percutaneous coronary intervention: results of the ARMYDA-5 PRELOAD (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) randomized trial.
J Am Coll Cardiol. 2010 Aug 10;56(7):550-7. doi: 10.1016/j.jacc.2010.01.067.
8
Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention.
J Am Coll Cardiol. 2010 Jul 20;56(4):254-63. doi: 10.1016/j.jacc.2010.05.008.
9
Timing of in-hospital coronary artery bypass graft surgery for non-ST-segment elevation myocardial infarction patients results from the National Cardiovascular Data Registry ACTION Registry-GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines).
JACC Cardiovasc Interv. 2010 Apr;3(4):419-27. doi: 10.1016/j.jcin.2010.01.012.
10
Intravenous platelet blockade with cangrelor during PCI.
N Engl J Med. 2009 Dec 10;361(24):2330-41. doi: 10.1056/NEJMoa0908629.
Zotero 插件